| Patent Number |
Title Of Patent |
Date Issued |
| 7202233 |
Alprazolam inclusion complexes and pharmaceutical compositions thereof |
April 10, 2007 |
| A pharmaceutical composition an inclusion complex and methods for treating patients and preparing said complex disclosed for transmucosal delivery comprising an inclusion complex of (a) alprazolam and (b) a water soluble 2-hydroxypropyl-beta-cyclodextrin, and a pharmaceutically acceptabl |
| 6255502 |
Pharmaceutical composition containing acid addition salt of basic drug |
July 3, 2001 |
| A pharmaceutical composition contains an acid addition salt of a basic drug and a fatty acid or bile acid. The acid addition salts thus formed exhibit enhanced transmucosal and transdermal penetration of the basic drug. The acid addition salts, an inclusion complex containing said salts |
| 6051734 |
Process for the optical resolution of 3-(p-chlorophenyl)-glutaramide |
April 18, 2000 |
| A process for the optical resolution of racemic 3-(p-chlorophenyl)glutaramide (GAM) into its R isomer R--COOH and its S isomer S--COOH, which process includes the steps of either:(1) reacting racemic 3-(p-chlorophenyl)-glutaramide dissolved in a suitable solvent with S-(-)-.alpha.-methyl |
| 5854226 |
Pharmaceutical composition |
December 29, 1998 |
| A pharmaceutical composition for oral administration for the treatment of acute pain and inflammation comprises an inclusion complex of a non-steroidal anti-inflammatory drug or a pharmaceutically acceptable salt thereof and a cyclodextrin, and a physiologically acceptable alkali agent |
| 5679660 |
Pharmaceutical composition comprising diclofenac and cyclodextrin |
October 21, 1997 |
| A method of preparing an injectable pharmaceutical or veterinary composition which comprises either diclofenac or a salt thereof and 2-hydroxypropyl beta-cyclodextrin, or an inclusion complex of diclofenac or a salt thereof and 2-hydroxypropyl beta-cyclodextrin, includes the step of |
| 5674854 |
Inclusion complex of beta-cyclodextrin and diclofenac, its preparation and use |
October 7, 1997 |
| An inclusion complex of diclofenac, preferably as diclofenac sodium, and an unsubstituted beta-cyclodextrin has the formula 1 molecule of diclofenac to 1 molecule of the unsubstituted beta-cyclodextrin and preferably from 5 to 11 water molecules. The inclusion complex may be formulated a |
| 5622716 |
Process for preparing a retard product containing diltiazem for a single daily administration |
April 22, 1997 |
| This invention is directed towards pellets and a process for manufacturing pellets of diltiazem HCl having a dissolution kinetic independent from pH. |
